Review Article
Pathogenetic, Clinical, and Prognostic Features of Adult t(4;11)(q21;q23)/MLL-AF4 Positive B-Cell Acute Lymphoblastic Leukemia
Table 1
The most common fusion partner genes of MLL: locations and functions.
| | 
 |  | Partner gene | Location | Function |  | 
 |  | AF4 | 4q21 Nuclear | Leads to RNApol-II activation and to transcriptional elongation |  | AF9 | 9p22 Nuclear | In association with ENL, DOT1L, and AF4, activator of RNApol-II kinase p-TEFb |  | ENL | 19p13.3 Nuclear | Elongation factor. In association with AF9, DOT1L  and AF4 activator of RNApol-II kinase p-TEFb |  | AF10 | 10p12 Nuclear | Transcriptional factor |  | ELL | 19p13.1 Nuclear | Elongation factor  interacts with a nuclear protein related to AF4 |  | AF6 | 6q27 Cytoplasmatic | Multi-domain protein involved in signaling and organization of cell junctions during embryogenesis |  | AF1P | 1p32 Cytoplasmatic | Part of the EGFR pathway,  involved in receptor-mediated endocytosis of EGF |  | 
 | 
 | 
| p-TEFb: positive transcription elongation factor b. p-TEFb phosphorylates serine residues of the carboxy-terminal domain of RNApol-II; RNApol-II: RNA polymerase II; CTD: carboxy-terminal domain kinase; DOT1L: DOT1-like, histone H3 methyltransferase; EGFR: epidermal growth factor receptor; EGF: epidermal growth factor. 
 |